Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

North America Clinical Trial Management Market Forecast 2021-2028

Published by Inkwood Research Product code 1003291
Published Content info 154 Pages
Delivery time: 2-3 business days
Price
Back to Top
North America Clinical Trial Management Market Forecast 2021-2028
Published: May 11, 2021 Content info: 154 Pages
Description

KEY FINDINGS

The North America clinical trial management market growth is anticipated to progress at a CAGR of 11.24% during the forecast period, 2021-2028. The region conducts clinical trials on a large scale. Also, the high awareness of CTM (clinical trial management) benefits and major pharmaceutical companies' presence propel market growth.

MARKET INSIGHTS

The United States and Canada are assessed for the North America clinical trial management market growth evaluation. In Canada, the growing trend of decentralization has enabled the scope of testing, with private players entering the segment. The clinical laboratory of the country receives funding from the Ministry of Health. The public labs, physicians' offices, private labs, and hospital labs generate revenue for diagnostics testing. Also, private labs are set to be integrated with hospital labs for clinical diagnostics. Many tests outsourced from the US are projected to benefit the market growth. The clinical laboratories are impacted by multiple trends, which affect the overall healthcare system. The rising deployment of new technologies like artificial intelligence and test automation has resulted in labs quickly adapting to shifting demographics.

Furthermore, the growing investments in clinical trials are accredited to its world-leading higher education system and the publicly-funded healthcare system. Also, the government is initiating several steps to increase R&D capabilities. Such developments are expected to influence market growth in Canada.

COMPETITIVE INSIGHTS

Some of the major companies in the market include Bioclinica Inc, Parexel International Corporation, Veeva Systems Inc, Mednet Solutions Inc, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 24393

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS - HEALTHCARE
  • 3.2. MARKET SCOPE
  • 3.3. KEY DRIVERS
    • 3.3.1. OUTSOURCING OF CLINICAL TRIALS
    • 3.3.2. GROWTH IN THE NUMBER OF CLINICAL TRIALS
    • 3.3.3. AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
    • 3.3.4. INCIDENCES OF CHRONIC DISEASES
    • 3.3.5. RESEARCH & DEVELOPMENT
  • 3.4. KEY RESTRAINTS
    • 3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 3.4.2. COST OF IMPLEMENTATION
    • 3.4.3. SECURITY CONCERNS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. THREAT OF SUBSTITUTION
    • 4.3.4. THREAT OF NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY END-USER

  • 5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 5.2. CLINICAL RESEARCH ORGANIZATIONS
  • 5.3. HEALTHCARE PROVIDERS

6. MARKET BY PRODUCT TYPE

  • 6.1. ENTERPRISE-BASED CTM
  • 6.2. SITE-BASED CTM

7. MARKET BY DEPLOYMENT MODEL

  • 7.1. WEB-BASED DEPLOYMENT
  • 7.2. ON-PREMISE DEPLOYMENT
  • 7.3. CLOUD-BASED DEPLOYMENT

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. NORTH AMERICA
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED STATES
      • 9.1.5.2. CANADA

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 10.2.2. ARISGLOBAL LLC
    • 10.2.3. BIOCLINICA INC
    • 10.2.4. BIO-OPTRONICS INC
    • 10.2.5. IBM CORPORATION
    • 10.2.6. MEDIDATA SOLUTIONS INC
    • 10.2.7. MEDNET SOLUTIONS INC
    • 10.2.8. ORACLE CORPORATION
    • 10.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: KEY PLAYERS OPERATING IN NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2020
  • FIGURE 6: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2021-2028 (IN $ MILLION)
  • FIGURE 7: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2020
  • FIGURE 10: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2021-2028 (IN $ MILLION)
  • FIGURE 11: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2021-2028 (IN $ MILLION)
  • FIGURE 12: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2020
  • FIGURE 13: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 14: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 15: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2021-2028 (IN $ MILLION)
  • FIGURE 16: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2020
  • FIGURE 17: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 18: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 19: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2021-2028 (IN $ MILLION)
  • FIGURE 20: NORTH AMERICA CLINICAL TRIAL MANAGEMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 21: UNITED STATES CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 22: CANADA CLINICAL TRIAL MANAGEMENT MARKET, 2021-2028 (IN $ MILLION)
Back to Top